FLASH NEWS LIVE

Cipla and Orbicular bring first generic liraglutide for obesity to U.S.

Cipla and Orbicular bring first generic liraglutide for obesity to U.S.

Cipla launches generic Saxenda (liraglutide) in the U.S. via partner Orbicular's FDA approval. What this means for GLP-1 generics competition, payers, and Cipla's peptide strategy. Read

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
Instagram Meta X LinkedIn Whatsapp